Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-randomized Study of the Avinger Ocelot System Used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries

NCT01537302 is registered in ClinicalTrials.gov with Avinger, Inc. as lead sponsor.

NCT NCT01537302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-randomized Study of the Avinger Ocelot System Used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries
Lead sponsor
Avinger, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
June 30, 2012
Enrollment
100 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

total atherosclerotic occlusion of femoral artery